Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia.
Amanda C PrzespolewskiAaron D GoldbergChetasi TalatiSalman FazalPankit VachhaniSrinivasa Reddy SanikommuSwapna ThotaJulian A WaksalBrian John BallChristopher A FamulareMaximilian StahlJeffrey BaronElizabeth A GriffithsJames E ThompsonKendra L SweetEunice S WangPublished in: Blood (2022)